<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00069589</url>
  </required_header>
  <id_info>
    <org_study_id>NIAMS-097</org_study_id>
    <secondary_id>HHSN268200682279C</secondary_id>
    <nct_id>NCT00069589</nct_id>
    <nct_alias>NCT00177073</nct_alias>
  </id_info>
  <brief_title>Alopecia Areata Registry</brief_title>
  <acronym>NAAR</acronym>
  <official_title>Alopecia Areata Registry and Immunogenetic Mechanisms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>M.D. Anderson Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Alopecia Areata Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>M.D. Anderson Cancer Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Alopecia areata is the loss of hair in patches that can proceed to loss of all hair (alopecia
      totalis or universalis). The purpose of the registry is to collect patient information and
      blood samples from people with alopecia areata.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Alopecia areata is a condition in which hair is lost either from part of the scalp, all of
      the scalp, or the entire body, and it affects 1% to 2% of the population. It is thought to be
      an autoimmune disease and in some cases the disease is hereditary. The Alopecia Areata
      Registry will collect information and blood samples from clinically well-characterized
      patients with these three forms of alopecia areata: alopecia partialis (patchy loss of the
      scalp hair), alopecia totalis (total loss of all scalp hair), and alopecia universalis
      (complete loss of all hair everywhere on the body). This will be a collection of patients in
      multi-generational families, twins, single patients with patchy, persistent transient
      alopecia areata or long-standing alopecia totalis/universalis and with controls (persons
      unaffected and not related to alopecia patients). Information from these patients will be
      used to search the human genome for disease-associated loci and/or genes. Researchers
      interested in doing pathophysiology or treatment studies of this disease will also be able to
      contact patients having the appropriate form of the disease for the studies in question.

      Patients who have been diagnosed with alopecia areata by a dermatologist will be eligible for
      the registry. Patients will fill out an information form online (alopeciaareataregistry.org).
      Patients who have a family history or specific types of alopecia will be invited to
      participate in a more detailed questionnaire and physical exam and have blood samples drawn.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>November 2001</start_date>
  <completion_date type="Anticipated">November 2099</completion_date>
  <primary_completion_date type="Anticipated">November 2099</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Alopecia Areata Registry</measure>
    <time_frame>Registration on-going</time_frame>
    <description>Database registration of participants via collection of participant epidemiology data.</description>
  </primary_outcome>
  <enrollment type="Anticipated">3100</enrollment>
  <condition>Alopecia Areata</condition>
  <condition>Alopecia Totalis</condition>
  <condition>Alopecia Universalis</condition>
  <condition>Autoimmune Hair Loss</condition>
  <condition>Alopecia Partialis</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      DNA will be analyzed to learn the link between gene markers of traites of alopecia areata.
      Sera will be used to analyse cytokins. Lymphocytes will be used for the creation of B-cell
      lines.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with alopecia areata (AA), both children and adults, who have been diagnosed by a
        physician with alopecia universalis, alopecia totalis, patchy persistent AA, or transient
        mild AA. Family members (related by blood) of these patients, preferably sib-pairs plus
        parents and multiplex families(persons with at least three family members with AA or
        alopecia universalis and alopecia totalis).

        Also, healthy individuals who are unaffected, non-blood related individuals and do not live
        in the same household with alopecia areata patient are needed as controls.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria

          -  Diagnosed with alopecia areata by a dermatologist

          -  United States resident

        Accepts Health Volunteers: Non blood-related individuals who are unaffected with alopecia
        areata and do not live in the same household with alopecia areata patient.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Madeleine Duvic, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>M.D. Anderson Cancer Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California, San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Colorado - UCHSC - Health Science Center at Fitzsimons</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80010-7163</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Minnesota</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Columbia University</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>M.D. Anderson Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.mdanderson.org/education-and-research/departments-programs-and-labs/programs-centers-institutes/alopecia-areata-registry/index.html</url>
    <description>Click here for more information on the Alopecia Areata Registry</description>
  </link>
  <link>
    <url>http://www.naaf.org</url>
    <description>National Alopecia Areata Foundation (NAAF) official website</description>
  </link>
  <results_reference>
    <citation>Duvic M, Norris D, Christiano A, Hordinsky M, Price V. Alopecia areata registry: an overview. J Investig Dermatol Symp Proc. 2003 Oct;8(2):219-21. Review.</citation>
    <PMID>14582678</PMID>
  </results_reference>
  <results_reference>
    <citation>Barahmani N, Yang Y, Lopez A, Duvic M. Atopic alopecia areata patients have increased serum Th1 Cytokine profiles. 66th Annual meeting of Society for Investigative Dermatology. St.Louis, MO, May 2005. JID 124 (4): A100, 2005.</citation>
  </results_reference>
  <results_reference>
    <citation>Breuer-McHam J, Hunzicker K, Barahmani N, Zhang Q, Babu D, Christiano A, Hordinsky M, Norris D, Price V, Duvic, M. Epidemiologic and disease associations in participants of the national alopecia areata (NAAR) registrants. Accepted by Society for Investigational Dermatology, April 12, 2004. JID 122 (3): A107, 2004.</citation>
  </results_reference>
  <results_reference>
    <citation>de Andrade M, Barahmani N, Hunzicker K, Zhang Q, Joan Breuer- McHam, Joyce Osei, Daniel Babu, Qingyi Wei, Reveille J, Duvic M. HLA Class II associations confirm alopecia areata phenotypic subsets. 66th Annual meeting of Society for Investigative Dermatology. St. Louis, MO, May 2005.JID 124 (4): A107, 2005.</citation>
  </results_reference>
  <results_reference>
    <citation>Barahmani N, de Andrade M, Slusser JP, Wei Q, Hordinsky M, Price VH, Christiano A, Norris D, Reveille J, Duvic M. Human leukocyte antigen class II alleles are associated with risk of alopecia areata. J Invest Dermatol. 2008 Jan;128(1):240-3. Epub 2007 Jul 19.</citation>
    <PMID>17637820</PMID>
  </results_reference>
  <results_reference>
    <citation>Ahmed AM, Barahmani N, Duvic M; National Alopecia Areata Registry. Familial alopecia areata and chronic thrombocytopenia. J Am Acad Dermatol. 2008 May;58(5 Suppl 1):S75-7. doi: 10.1016/j.jaad.2007.05.017.</citation>
    <PMID>18489053</PMID>
  </results_reference>
  <results_reference>
    <citation>Rodriguez TA, Duvic M; National Alopecia Areata Registry. Onset of alopecia areata after Epstein-Barr virus infectious mononucleosis. J Am Acad Dermatol. 2008 Jul;59(1):137-9. doi: 10.1016/j.jaad.2008.02.005. Epub 2008 Mar 7.</citation>
    <PMID>18329131</PMID>
  </results_reference>
  <results_reference>
    <citation>Martinez-Mir A, Zlotogorski A, Gordon D, Petukhova L, Mo J, Gilliam TC, Londono D, Haynes C, Ott J, Hordinsky M, Nanova K, Norris D, Price V, Duvic M, Christiano AM. Genomewide scan for linkage reveals evidence of several susceptibility loci for alopecia areata. Am J Hum Genet. 2007 Feb;80(2):316-28. Epub 2007 Jan 5.</citation>
    <PMID>17236136</PMID>
  </results_reference>
  <results_reference>
    <citation>Barahmani N, de Andrade M, Slusser JP, Zhang Q, Duvic M. Major histocompatibility complex class I chain-related gene A polymorphisms and extended haplotypes are associated with familial alopecia areata. J Invest Dermatol. 2006 Jan;126(1):74-8.</citation>
    <PMID>16417220</PMID>
  </results_reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 29, 2003</study_first_submitted>
  <study_first_submitted_qc>September 29, 2003</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 30, 2003</study_first_posted>
  <last_update_submitted>February 15, 2018</last_update_submitted>
  <last_update_submitted_qc>February 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Baldness</keyword>
  <keyword>Autoimmunity</keyword>
  <keyword>Hair</keyword>
  <keyword>Alopecia Areata</keyword>
  <keyword>Alopecia Partialis</keyword>
  <keyword>Alopecia Totalis</keyword>
  <keyword>Alopecia Universalis</keyword>
  <keyword>Autoimmune Hair Loss</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alopecia</mesh_term>
    <mesh_term>Alopecia Areata</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

